drugset / Trial / NCT02784457

Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome

NCT02784457

Phase 2 Completed 84 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelTreatment

Summary

Efficacy of the use of GnRH antagonist in treatment of those who develop early-onset severe ovarian hyperstimulation syndrome and had cancelled embryo transfer

Timeline

Start
2014-06
Primary completion
2015-12
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetrorelix Other / unclassified

Indications

No indication recorded.